Skip Navigation

JNCI Journal of the National Cancer Institute 2002 94(22):1670-1672; doi:10.1093/jnci/94.22.1670
© 2002 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Bankhead, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bankhead, C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 22, 1670-1672, November 20, 2002
© 2002 Oxford University Press

NEWS

Chemoradiation Protocols Offer Only Incremental Gains for Pancreatic Cancer Patients

Charles Bankhead

The first 10% of the full text of this article appears below.

Despite the apparent success of several chemoradiation regimens in converting patients with inoperable pancreatic cancer to resectable status, investigators at a recent meeting of the American Society for Therapeutic Radiation and Oncology (ASTRO) lamented the lack of progress against a cancer that continues to have an almost universally poor prognosis and called for new therapeutic strategies to improve outcomes.

"The trials in pancreatic cancer all have a little bit of the feel of rearranging the deck chairs on the . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?